Specifically, in patients with ESCC, high levels of Fn in tumor tissue were not only significantly associated with shorter recurrence-free survival (RFS) but also predicted poorer response to neoadjuvant chemotherapy (Yamamura et al., 2019). This evidence concerns the gene FN1 and esophageal squamous cell carcinoma.